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The CHRNA5-CHRNA3-CHRNB4 gene cluster, encoding the α5, α3, and β4 nicotinic
acetylcholine receptor (nAChR) subunits, has been linked to nicotine dependence. The
habenulo-interpeduncular (Hb-IPN) tract is particularly enriched in α3β4nAChRs. We
recently showed that modulation of these receptors in the medial habenula (MHb) in
mice altered nicotine consumption. Given that β4 is rate-limiting for receptor activity and
that single nucleotide polymorphisms (SNPs) in CHRNB4 have been linked to altered risk
of nicotine dependence in humans, we were interested in determining the contribution
of allelic variants of β4 to nicotine receptor activity in the MHb. We screened for
missense SNPs that had allele frequencies >0.0005 and introduced the corresponding
substitutions in Chrnb4. Fourteen variants were analyzed by co-expression with α3. We
found that β4A90I and β4T374I variants, previously shown to associate with reduced risk
of smoking, and an additional variant β4D447Y, significantly increased nicotine-evoked
current amplitudes, while β4R348C, the mutation most frequently encountered in
sporadic amyotrophic lateral sclerosis (sALS), showed reduced nicotine currents. We
employed lentiviruses to express β4 or β4 variants in the MHb. Immunoprecipitation
studies confirmed that β4 lentiviral-mediated expression leads to specific upregulation
of α3β4 but not β2 nAChRs in the Mhb. Mice injected with the β4-containing virus
showed pronounced aversion to nicotine as previously observed in transgenic Tabac mice
overexpressing Chrnb4 at endogenous sites including the MHb. Habenular expression of
the β4 gain-of-function allele T374I also resulted in strong aversion, while transduction with
the β4 loss-of function allele R348C failed to induce nicotine aversion. Altogether, these
data confirm the critical role of habenular β4 in nicotine consumption, and identify specific
SNPs in CHRNB4 that modify nicotine-elicited currents and alter nicotine consumption in
mice.
Keywords: medial habenula, nicotine consumption, SNP, lentivirus transduction, electrophysiological recordings,
smoking dependence
INTRODUCTION
As the leading preventable cause of cancer and death, nicotine use
and dependence has been the subject of a multitude of genetic
studies in the past decade. By far, the strongest and most replica-
ble evidence exists for a role of the CHRNA5-A3-B4 gene cluster
on chromosome 15q25 in nicotine addiction, which encodes three
subunits of nicotinic acetylcholine receptors (nAChR). Two sin-
gle nucleotide polymorphisms (SNPs) in particular, rs16969968
in CHRNA5 and rs1051730 in CHRNA3, have been linked to
smoking-related behaviors in multiple studies (Bierut et al., 2007;
Saccone et al., 2007; Thorgeirsson et al., 2008). Though not as
strongly linked, the β4 subunit has been nominally associated
with smoking quantity in several studies (Saccone et al., 2009;
Harari et al., 2012). Variants located upstream of CHRNB4 affect
the age at which individuals transition to daily and habitual smok-
ing (Kapoor et al., 2012), while another study found that SNP
rs12914008 in CHRNB4 is associated with less abstinence over
time (Sarginson et al., 2011). Rare missense variants in CHRNB4
(T375I and T91I) and in CHRNA3 (R37H) are associated with
lower risk for nicotine dependence and fewer cigarettes per day
(Haller et al., 2012).
Despite the preponderance of evidence linking the CHRNA5-
A3-B4 gene cluster to nicotine-related diseases, very little evidence
exists as to how mutations in these receptors alter their func-
tion. Cumulative data from rodent models suggest that CHRNA5
and CHRNB4, particularly in the medial habenula (MHb)-
interpeduncular (IPN) circuit, mediate the aversive properties
of nicotine (Salas et al., 2009; Fowler et al., 2011; Frahm et al.,
2011) and withdrawal (Salas et al., 2009; Gorlich et al., 2013). For
example, animals lacking the α5 nAChR subunit self-administer
more nicotine (Fowler et al., 2011) and do not display somatic
signs of nicotine withdrawal (Salas et al., 2009). Restoration
of CHRNA5 to the MHb leads to normalization of nicotine
consumption, i.e., the mice reach a plateau in administration,
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suggesting that it is the aversive aspect that limits intake (Fowler
et al., 2011). Overexpression of the entire human gene cluster in
mice leads to increased sensitivity to nicotine with higher acti-
vation of the MHb and reduced activation of the VTA (Gallego
et al., 2012). We previously demonstrated that overexpression of
the β4 nAChR subunit in the Tabac transgenic mouse model is
sufficient to increase sensitivity to the aversive properties of nico-
tine and decrease consumption. Overexpression of β4 also leads
to increased surface expression of α3, as β4 is the rate-limiting
subunit for assembly (Frahm et al., 2011). In particular we previ-
ously showed that β4 is rate-limiting for α3β4 activity since when
overexpressed it increases the density of α3β4 receptors at the
plasma membrane, as well as potentiates α3β4 currents in vitro
and in a transgenic mouse model (Frahm et al., 2011). The ability
of β4 to enhance nicotine-evoked currents depends on a unique
single residue S435, which does not exist in other β nAChR sub-
units and can confer this capability to β2 when introduced in the
corresponding arginine residue (Frahm et al., 2011).
This critical residue (S435) in β4 is located within the
membrane-associated stretch in the intracellular vestibule of
the receptor (Frahm et al., 2011). Sequence alignments identi-
fied other SNPs mapping to the intracellular vestibule, one of
them being the most common SNP associated with nicotine use,
rs16969968, leading to an amino acid substitution (D398N) in the
α5 subunit. Functional analysis of this SNP in α5 demonstrated
that mutation of this residue within the highly electrostatically
charged intracellular vestibule of the nAChR significantly reduces
nicotine-evoked currents. Behaviorally, this genetic variant had
profound effects: Tabac mice with strong aversion to nicotine
due to increased expression of β4, reverted to nicotine prefer-
ence upon viral-mediated expression of the α5 D398N variant
(Frahm et al., 2011). Given that several SNPs in β4 have been
identified in humans, particularly in the intracellular vestibu-
lar region, we were interested in determining their contribution
to α3β4 receptor function. Based on reported validation studies
and heterozygosity rates, we selected 14 out of 67 missense SNPs
identified in the coding region of CHRNB4. Expression of these
missense β4 variants in oocytes indicated that amino acid substi-
tutions corresponding to 12 of these 14 SNPs led to changes in
the electrophysiological properties of the channel (Liang et al.,
2005; Haller et al., 2012). We further analyzed four of these
SNPS in hippocampal neurons, and found that the two vari-
ants most associated with decreased risk of nicotine dependence,
A90I and T374I (Haller et al., 2012), and a third variant D447Y,
augmented nicotine-mediated α3β4 nAChR currents, while the
fourth analyzed SNP, previously associated with sporadic amy-
otrophic lateral sclerosis (sALS) (Moriconi et al., 2011), reduced
nicotine currents. Mice injected in the MHb with lentiviruses
carrying the wild-type β4 subunit or β4 rare missense variants,
showed aversion or preference to nicotine, depending on whether
the variant increased or decreased nicotine currents. These results
indicate that nicotine consumption is regulated by β4∗ nAChR
activity in the MHb.
MATERIALS AND METHODS
ANIMALS
Transgenic Tabac mice were obtained from GENSAT (Gong et al.,
2003) and backcrossed to a C57BL/6 background. All transgenic
animals used for experiments were hemizygous. C57BL/6 male
mice were purchased from Charles River (Germany) and allowed
to habituate to the facility for 1 week before use in lentiviral exper-
iments. Mice were housed with ad libitum access to food and
water in a room air conditioned at 22–23◦C with a standard 12 h
light/dark cycle, with a maximum of five animals per cage. All
procedures were in accordance with ethical guidelines laid down
by the local governing body and approved by the Landesant Für
Gesundheit und Soziales, Berlin and the Institutional animal use
and care committee IACUC, New York).
TWO-ELECTRODE VOLTAGE-CLAMP RECORDINGS OF XENOPUS LAEVIS
OOCYTES
cDNA encoding for the mouse α3 and β4 nAChR subunit was
subcloned into the pCS2A plasmid for oocyte expression. Site-
directed mutations corresponding to the selected SNPs were
introduced in the β4 nAChR subunit using QuikChange Site-
Directed mutagenesis kit (Stratagene, catalog # 200519). RNA
transcripts were prepared using the mMESSAGE mMACHINE
kit (Ambion, catalog # AM1344M) as described (Ibanez-Tallon
et al., 2004). Oocytes were surgically extracted and prepared
as described (Sturzebecher et al., 2010). For electrophysiolog-
ical recordings of the 14 β4 variants shown in Figure 1, each
oocyte was injected with 20 nl of a cRNA mix containing 1 ng of
α3 + 1 ng of β4 (β4 wt or each of the 14 indicated β4 variants).
FIGURE 1 | Selected β4 missense variants and nicotine-evoked currents
in oocytes. (A) Graphic representation of the β4nAChR subunit indicating
the location of the rare missense variants at the extracellular and
intracellular loops of the receptor subunit. (B) Electrophysiological
macroscopic recordings in Xenopus laevis oocytes injected with equal
amounts of the wild type transcripts for α3 and β4 (1 ng α3 + 1ng β4) or
with equal amounts of transcripts for wild type α3 and each of the indicated
β4 variants (n = 10 oocytes per condition). The residues in blue indicate the
mouse variants corresponding to the two human β4 SNPs shown to have
increased nicotine currents. Red indicates two additional residues that
significantly differ from the wild type β4nAChR subunit in gray. All values
are expressed as mean ± s.e.m. One-way ANOVA F(14, 91) = 9.1,
p < 0.0001; Dunnett’s Multiple Comparison post-hoc ∗p < 0.05,
∗∗∗p < 0.001.
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For electrophysiological recordings of the β4 variants A90I, T374I,
D447Y, and R348C shown in Figure 2, each oocyte was injected at
1:1 and 1:10 ratios, with either 1 ng of α3 + 1 ng of β4 (wt or vari-
ants): or 1 ng of α3 + 10 ng of β4 (wt or variants). Macroscopic
currents were recorded 4 days after injection with a GeneClamp
500 B amplifier (Axon Instruments) using a two-electrode voltage
clamp with active ground configuration as described in Frahm
et al. (2011). Nicotine tartrate salt (Sigma-Aldrich, catalog #
N5260) was applied at the concentration of 1mM. Mean fold cur-
rent increase was evaluated by dividing peak amplitudes of 5–10
single oocytes expressing receptors containing each of the poly-
morphic variants of β4 nAChR by peak amplitudes of the ones
carrying native β4 nAChR at 1:1 and 1:10 ratio.
LENTIVIRUS PRODUCTION
Recombinant lentiviral vectors were prepared using transient
transfection of HEK293T cells as described in (Auer et al., 2010).
WHOLE-CELL PATCH CLAMP RECORDINGS IN PRIMARY
HIPPOCAMPAL NEURONS
Dissociated hippocampal cultures were prepared from embry-
onic day 19 rat embryos and prepared as described in (Auer
et al., 2010). After 9 days in culture, neurons were infected with
lentiviruses carrying the α3 and one of the variants of β4 nAChR
subunit. Three to four days after lentivirus infection, nicotine-
elicited currents were analyzed by whole-cell patch-clamp record-
ings. The internal pipette solution contained (mM): 130KCl,
2MgCl2, 0.5 CaCl2, 5 EGTA, 10 HEPES, pH 7.3, osmolarity 280
(resistance 5–7M). 30μM nicotine tartrate was locally applied
FIGURE 2 | Increased currents by overexpression of β4 variants.
(A) Representative traces of two-electrode-voltage-clamp recordings in
oocytes injected with either equal amounts of α3 and β4 transcripts (1 ng
α3 + 1ng β4, 1:1 ratio; black traces) or with 10 times more of the β4
transcript (1 ng α3 + 10ng β4, 1:10 ratio; red traces). Horizontal line above
each trace indicates nicotine (1mM) application. (B) Bar graph indicates the
fold increase of the current amplitude elicited by 1mM nicotine with
respect to a3b4 wt oocytes injected at 1:1 (n = 10 oocytes per condition)
for oocytes injected with 1:1 or 1:10 rations of the indicated β4 variants
A90I, T374I, D447Y, and R348C. All values are expressed as mean ± s.e.m.
(50ms, 18–10 psi) with a pressure device (PR-10, ALA Scientific
Instruments) connected to a focal perfusion system (VM4, ALA
Scientific Instruments) controlled with a trigger interface (TIB
14S, HEKA). The pipette was moved within 15–20μm of the
recorded cell with a motorized micromanipulator (LN mini 25,
control system SM-5, Luigs and Neumann) for drug application
and retracted after the end of the puff to minimize desensitiza-
tion. Currents were recorded with a HEKA amplifier (EPC 10)
using PatchMaster software (V2.20, HEKA), and analyzed with
FitMaster software (V2.3, HEKA). Membrane potential was held
at −70mV.
STEREOTACTIC VIRAL INJECTIONS IN THE MHb
Stereotactic injections were performed as described in Frahm
et al. (2011). Briefly, 1μl of concentrated lentivirus (2–5 ×
108 TU/ml) was injected bilaterally into the MHb of 8 week-old
C57Bl/6 male mice at each of the following coordinates from
bregma (Franklin and Paxinos, 2008): antero-posterior −1.40
and −1.74, lateral ±0.33, dorso-ventral (from skull level) −2.7
and −2.74. Behavioral experiments started 2 weeks after injection
with either the wild type β4-carrying lentivirus pFU-β4-IRES-
EGFP or virus carrying one of the β4-point mutants. Expression
of eGFP using the same pFU lentiviral vectors has been shown
after just 1 week (Dittgen et al., 2004). Immunoprecipitation
assays or sacrifice followed by transcardial perfusion with 4%
paraformaldehyde in PBS were done 4 weeks post-injection.
Verification of the injection site for each animal in the behavioral
assays was performed on 40μm coronal brain sections immunos-
tained with rabbit polyclonal anti-GFP antibody (Invitrogen,
catalog # A11122) diluted 1:1000 as previously described (Frahm
et al., 2011; Gorlich et al., 2013). Animals with lentiviral injec-
tion placement outside the MHb were excluded from behavioral
analysis, leaving 6–8 animals per group.
IMMUNOPRECIPITATION OF [125I] EPIBATIDINE-LABELED RECEPTORS
BY SUBUNIT-SPECIFIC ANTIBODIES
Four weeks post-injection, habenula were dissected from
C57BL/6 mice injected with either the β4-carrying lentivirus
pFU-β4-IRES-EGFP or control virus pFU–PE, and were pro-
cessed as previously described (Grady et al., 2009). Briefly, 2%
Triton X-100 habenula extracts were preincubated with 2μM
αBgtx (Tocris, Bristol, UK catalog # 2133), labeled with 0.5 nM
[125I] Epibatidine (specific activity 2200Ci/mmol, Perkin Elmer
catalog #NEX358) and incubated overnight with a saturating con-
centration of affinity-purified anti-subunit α3, β4, and β2 specific
polyclonal IgG produced and characterized by Grady et al. (2009).
These polyclonal antibodies [supplementary Table of Grady et al.
(2009)] were produced against the following peptide sequences
TRPTSTEEDAPKTRNFYGAELSNLNC in the cytosolic loop of
mouse α3, VSSHTAGLPRDARLRSSGRFREDLQEALEG in the
cytosolic loop of rat β4, and RQREREGAGALFFREAPGADSCTY
in the cytosolic loop of human β2. As described in (Grady et al.,
2009), the specificity of the anti β4 and anti β2 antibodies, was
tested by immunoprecipitation using 3H- or 125I-Epibatidine
labeled receptors obtained from tissues of wt and β4 and β2
KO mice respectively; specific immunopreciptation was obtained
in wt but not in the respective KO mice. The anti-α3 antibody
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specificity was determined by specific immunoprecipitation of
anti-α3 antibodies only in HEK cells transfected with the α3β4
or α3β2 subtypes and not in HEK cells transfected with the
human α2β2, α2β4, α4β2, and α4β4 subtypes. After incubating
with the specific polyclonal antibodies, the immunoprecipitated
fractions from habenula extracts were recovered by incubating
the samples with beads containing bound anti-rabbit goat IgG
(Technogenetics). The level of antibody immunoprecipitation
was expressed as femtomoles of immunoprecipitated receptors
per milligram of protein.
TWO-BOTTLE NICOTINE CONSUMPTION
The two-bottle drinking test was used to measure the consump-
tion to nicotine relative to water, as described in Meliska et al.
(1995), Robinson et al. (1996), Butt et al. (2005), Glatt et al.
(2009). We used a moderate dose of 50μg/ml nicotine (Matta
et al., 2007) since at this dose we previously observed a large dif-
ference in nicotine consumption between wild type and Tabac
mice (Frahm et al., 2011). Adult male Tabac mice or lentiviral
injected C57BL/6 mice were single-housed and tested in their
home cages. For the first 3 days, nicotine naïve mice were pre-
sented with two bottles of 2% saccharin in tap water for acclima-
tion to the test conditions. After 3 days, the volume consumed
from each bottle was recorded to determine any baseline side
preference. The difference in volume before and after 3 day con-
sumption was measured by weighting the cage bottles (0.5ml is
the smallest difference that can be measured by weighting). After
the acclimation period, the solution in one of the bottles was
replaced with nicotine tartrate (50μg/ml) in 2% saccharin in tap
water, and the volume drunk from each bottle was measured after
3 days. To account for side-bias, nicotine was presented on the
side that was less preferred. Bottles were equipped with sipper
tubes with ball bearings to prevent volume loss by leakage. Percent
nicotine consumption was expressed as a ratio of the volume of
nicotine solution consumed divided by the total fluid intake (ml
nicotine/ml total × 100).
STATISTICAL ANALYSIS
All data are presented as the mean ± s.e.m. For electrophysiolog-
ical and behavioral tests, ANOVA followed by Dunnett’s multiple
comparisons post-hoc was used to analyze the data (GraphPad
Prism5). The number of oocytes, neurons, or animals per group
is indicated in the figure legend. The statistical values (F, degrees
of freedom) can be found in the results section. Student’s t-test
was used to analyze the immunoprecipitation data
RESULTS
SELECTION OF MISSENSE SNPS IN CHRNB4 FOR FUNCTIONAL
ANALYSIS
We searched the SNP database formissense polymorphisms in the
coding region (cSNPs) of the CHRNB4 gene (http://www.ncbi.
nlm.nih.gov/projects/SNP/snpref.cgi?geneId=1143). The data-
base reports 67missense variants with very low or not determined
minor allele frequency (MAF). Given that validation studies have
been reported for only a third of these missense variants, and that
informative SNPs need to be polymorphic on the two different
alleles (Li et al., 2007), we selected 14 variants that had either an
heterozygosity index p ≥ 0.004, or were validated by frequency
or genotype data (minor alleles observed in at least two chromo-
somes) (Table 1). We introduced the corresponding mutations
in the mouse Chrnb4 gene by site-directed mutagenesis of the
indicated nucleotides in the mouse sequence (Table 1). It is inter-
esting to note that 8 of the 14 selected SNPs result in a change in
the charge or hydrophobicity of the aminoacid residue and that
6 of these SNPs correspond to mutations of arginine (R) residues
(positively charged) (Table 1). Given that all of these variants are
Table 1 | Missense SNPs in CHRNB4 and corresponding variants introduced in the mouse sequence.
rs number MAF HET hMissense mMissense mMut Aa charge SIFT
71653605 ND 0.039 R22C R21C TGC + to O TOLERATED
72648898 ND 0.004 R39C R38C TGC + to O DAMAGING
75495090 0.0032 0.012 N41S N40S AGC O to O DAMAGING
12914008 0.0165 0.062 T91I A90I ATC H to H DAMAGING
149832833 0.0005 0.001 R109H R108H CAC + to + TOLERATED
56095004 0.0037 0.012 R136Q R135Q CAG + to O TOLERATED
143402850 ND 0.001 V311I V310I ATC H to H TOLERATED
79914661 ND 0.02 R322S R321S AGT + to O DAMAGING
56235003 0.0051 0.014 R349C R348C TGC + to O DAMAGING
61737499 0.0005 0.016 T375I T374I ATC O to H TOLERATED
75124790 ND 0.129 N391T N394T ACC O to O TOLERATED
56317523 0.0018 0.004 A435V A348V GTA H to H DAMAGING
56258098 ND 0.005 D444Y D447Y TAT − to O TOLERATED
79647370 ND 0.002 F462Y F465Y TAC H to O TOLERATED
Reference ID numbers (rs number), validated minor allele frequencies (MAF) and heterozygosity rates (HET) of the SNPs in the coding sequence of CHRNB4
that cause non-synonymous missense mutations in human carriers (hmissense). The corresponding missense variants were introduced in the mouse sequence
(mmissense) with the indicated nucleotide substitutions (mmut) in bold. In most cases the missense variant changed the charge of the aminoacid (Aa) (indicated
as +, positively charged; O, polar no charge; − negatively charged; H, hydrophobic). The last column indicates the SIFT (Sorting Intolerant from Tolerant) value
predicts the impact of a residue substitution on protein function (http://siftdna.org/www/Extended_SIFT_chr_coords_submit.html).
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in the extracellular domain and intracellular loop of the β4 sub-
unit (Figure 1A), this suggests that some of these variants may
alter the hydrophobicity or electrostatic charge of these functional
domains in the β4 subunit.
NICOTINE-ELICITED CURRENTS OF α3β4 nAChR AND MISSENSE
β4 VARIANTS
To begin to assess the influence of the selected missense β4
variants on nicotine-mediated currents, we performed two elec-
trode voltage clamp recordings in Xenopus laevis oocytes. Oocytes
were co-injected with equal amounts of transcripts encoding the
α3 nAChR subunit and wild-type (wt) β4 or α3 and each of the
β4 point mutants (1 ng of α and 1 ng of β per oocyte). As shown
in Figure 1, nicotine-elicited currents were observed for all the
selected missense β4 variants except for the N394T and F463Y
variants that failed to express at the oocyte surface. We observed
that two variants (red bars, Figure 1) significantly differed from
α3β4 control currents. These were the β4 R348C variant (cor-
responding to the human R349C) which showed significantly
reduced currents (0.12 ± 0.43 normalized amplitude increase) in
agreement with previous reports (Moriconi et al., 2011; Richards
et al., 2011), and the D447Y variant (corresponding to the human
D444Y) that showed significantly larger currents (3.13 ± 0.24
normalized amplitude increase). This rare SNP reported by Weiss
and colleagues (Weiss et al., 2008) has not been previously char-
acterized functionally. The 8 variants indicated in black bars
(Figure 1) exhibited currents that did not differ significantly from
control oocytes injected with α3β4wt (average current amplitude
for a3b4 wt 0.88 ± 0.20μA) and were not further analyzed. The
variants A90I (human T91I variant) and T374I (human T375I),
showed slightly higher currents (blue bars in Figure 1) that were
not significantly different from wt. However, since these 2 vari-
ants are the only SNPs in CHNRB4 that have been associated with
nicotine dependence (Haller et al., 2012), we sought to further
characterize them in neurons. Based on these results and criteria
we selected the variants A90I, R348C, T374I, and D447Y of the β4
subunit for further analysis.
β4 MISSENSE VARIANTS MAINTAIN THE β4-RATE-LIMITING
PROPERTY
We previously showed that β4 is rate-limiting for α3β4 activity as
it has the capability to increase the density of α3β4 receptors at the
plasma membrane, as well as to potentiate α3β4 currents when
overexpressed in vitro and in a transgenic mouse model (Frahm
et al., 2011). The ability of β4 to enhance nicotine-evoked currents
depends on a unique single residue S435, which does not exist in
other β nAChR subunits and can confer this capability to β2 when
introduced in the corresponding arginine residue (Frahm et al.,
2011).
To evaluate whether this unique property of β4 was conserved
in the four selected β4 point mutants we next tested these point
variants in overexpression conditions. Oocytes were injected with
equal amounts of α3 and β4 transcripts (1:1 ratio) and com-
pared to oocytes injected with 10 times more of the β4 transcript
than of α3 (1:10 ratio). Representative traces of these record-
ings are shown in Figure 2A. It is interesting to note that the
β4 R348C mutant not only leads to reduced agonist-induced
currents, but also has slower kinetics of decay during ligand appli-
cation (Figure 2A), consistent with reported electrophysiological
recordings in cells (Moriconi et al., 2011). Upon overexpression,
as previously observed for the native β4 (Frahm et al., 2011),
nicotine-evoked currents increased 6.54 ± 0.43 fold for native
β4, 6.12 ± 0.33 fold for β4A90I, 5.85 ± 0.68 fold for β4T374I,
and 6.85 ± 0.07 fold for β4D447Y (Figure 2B). The β4R348C
variant, which had lower currents at the 1:1 ratio (0.30 ± 0.030
fold amplitude normalized to α3β4wt, also showed increased cur-
rents reaching 2.97 ± 0.30 fold increase upon 1:10 overexpression
(Figure 2B).
LENTIVIRAL CONSTRUCTS FOR TARGETED EXPRESSION OF
α3β4 nAChRs IN NEURONS
In order to analyze α3β4 nAChR currents in neurons and in
mice, and evaluate the influence of the β4 missense variants,
we constructed lentiviral vectors. To avoid potential problems
with trafficking or assembly, we designed bicistronic constructs
instead of generating fluorescent fusion proteins. The pFU-β4-
IRES-EGFP construct contains the mouse β4 subunit (native or
variant) followed by an internal ribosome entry site (IRES) and
EGFP to monitor the level of infection, while pFU-α3-IRES-
mCherry was designed to express the mouse α3 subunit and
mCherry (Figure 3). As a control, we used pFU-PE, a lentivirus
encoding the transmembrane domain of the PDGF receptor fused
to EGFP (PE) (Auer et al., 2010). Prior to functional assays, the
infection capabilities and reporter gene expression of the gener-
ated lentiviral particles were assayed in cultured rat hippocampal
neurons. Bright direct fluorescence was observed in the soma
and dendrites of neurons transduced with the α3 and β4 viruses
(Figure 3).
FIGURE 3 | Schematic representation of the viral constructs for
expression of α3 and β4nAChRs in neurons and for stereotactic
injections in the Mhb. Graphic representation of the lentiviral vectors
encoding β4 (pFU-β4-IRES-EGFP) and α3 (pFU–α3-IRES-mCherry). The
modules for viral expression are indicated: , packaging sequence; RRE,
rev-responsive element; cPPT, central polypurine tract; Prom, human
ubiquitin 2 promoter; IRES, internal ribosome entry site sequence; WPRE,
woodchuck hepatitis B virus post-transcriptional regulatory element.
Photomicrographs of direct fluorescence signal in rat hippocampal neurons
transduced with the indicated β4 and α3 lentiviruses.
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ELECTROPHYSIOLOGICAL RECORDINGS OF β4 MISSENSE VARIANTS IN
NEURONS
To further evaluate the modulatory effect of β4 variants on the
response of neurons to nicotine, we performed patch clamp
analyses in cultured rat hippocampal neurons co-transduced
with lentivirus for α3 and β4 or β4 variants. Representative
α3β4 nAChR currents recorded in co-transduced neurons upon
pressure application of 30μM nicotine are shown in Figure 4A.
Quantitation of average current amplitudes revealed that the β4
point mutants A90I, T374I, and D447Y exhibited significantly
larger responses to nicotine and that the R348C variant led to
reduced nicotine-evoked current amplitudes, when compared to
native α3β4 responses (Figure 4B). These results confirmed our
electrophysiological studies in oocytes (Figure 1) and whole-cell
recordings in transfected cells (Moriconi et al., 2011; Haller et al.,
2012).
FIGURE 4 | Electrophysiological characterization of β4 variants in
primary rat hippocampal neurons. (A) Representative traces of
nicotine-elicited currents in primary hippocampal neurons transduced with
α3- and β4-carrying lentivirus (B) Quantification of nicotine-evoked currents
show increased response when neurons were transduced with A90I, T374I,
or D447Y β4 variants, while neurons transduced with point mutation R348C
resulted in decreased response to nicotine (n = 15–22 neurons per
condition). All values are expressed as mean ± s.e.m. One-Way ANOVA
F(4, 79) = 14.58, p < 0.0001; Dunnett’s Multiple Comparison post-hoc
∗p < 0.05, ∗∗∗p < 0.001.
In vivo LENTIVIRAL OVEREXPRESSION OF β4 RECONSTITUTES
INCREASED α3β4∗ IN THE MHb OF MICE
We have recently shown that transgenic Tabac mice expressing
elevated levels of Chrnb4 at endogenous sites, including the MHb,
had increased cytisine resistant-125I-epibatadine ligand binding
sites and increased α3β4∗ nAChR currents, demonstrating that
β4 has the ability to upregulate the number of α3β4∗ recep-
tors (Frahm et al., 2011). We wanted to assess whether selective
overexpression of β4 only in the MHb would be able to repro-
duce this α3β4 upregulation in vivo. For this reason mice were
sterotactically injected bilaterally in the MHb with either the β4-
containing lentivirus or the pFU-PE control virus (Figure 5A).
Quantification of α3, β4, and β2 subunits was performed by
immunoprecipitation assays from 2% Triton X-100 habenula
FIGURE 5 | Lentiviral mediated expression of β4 in the Mhb and
quantification by immunoprecipitation. (A) Representative coronal brain
sections of mice injected with pFU-PE control virus or with the β4
containing virus pFU-β4-IRES-EGFP. (B) Quantitative immunoprecipitation,
expressed as fmol/mg of protein of the solubilized [125I]epibatidine-labeled
receptors immunoprecipitated by the anti-α3, -β4, or -β2 subunit specific
antibodies (Grady et al., 2009). The solubilized [125I]epibatidine-labeled
receptors were obtained from the habenula and hippocampus of C57BL/6
mice injected with either control virus or virus carrying the β4 nAChR
subunit (n = 10 mice per group). ∗∗p < 0.01, Student’s t-test.
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extracts obtained after solubilization of the membranes obtained
from the habenula region of injected mice (Figure 5B). The hip-
pocampus was used as an uninfected control region (Figure 5C).
The indicated α3, β4, and β2 values correspond to the femtomoles
of 125I-epibatidine labeled receptors immunoprecipitated permg
of protein. As shown in Figure 5B, there is a very pronounced
increase in α3 and β4-containing receptors, but no change in the
level of β2 receptors, in the habenula of mice injected with the
β4 lentivirus. This suggests that, in the habenula, the β2 subunit
is not coassembled in receptors containing the β4 subunit. The
immunoprecipitations from hippocampus of mice injected in the
MHb clearly indicate that there is no change in α3β4-containing
and in β2-containing receptors, as expected from the restricted
lentiviral-mediated expression of β4 by stereotactic injection.
These results demonstrate that β4, as the rate-limiting subunit for
assembly, can increase α3 incorporation and subsequent surface
expression.
LENTIVIRAL-MEDIATED EXPRESSION OF MISSENSE β4 VARIANTS IN
THE MHb ALTERS NICOTINE CONSUMPTION IN MICE
Given that lentiviral expression of only β4 is sufficient to upreg-
ulate α3β4 receptors in vivo in the habenula (Figure 5), and
that transgenic Tabac mice expressing elevated levels of Chrnb4
at endogenous sites, including the MHb, consume less nico-
tine (Frahm et al., 2011), we wanted to confirm the critical role
of the MHb in nicotine consumption by employing lentiviral-
mediated transduction to overexpress β4 in this particular brain
region. We measured nicotine consumption using the two-bottle
drinking test. Because nicotine solutions have bitter taste, con-
trol experiments were performed with a bitter solution (quinine).
These measurements did not show significant differences in con-
sumption between wt and Tabac mice (Frahm et al., 2011). We
determined the relative volume of drank nicotine (diluted in 2%
saccharin) compared to 2% saccharine sweetened water in wt,
Tabac mice and wt mice injected with either a control virus, or
virus encoding β4 or the β4 variants T374I and R348C. As shown
in Figure 6, lentiviral-mediated overexpression of β4 in the MHb
of injected wild-type mice is sufficient to cause a strong aver-
sion to 50μg/ml nicotine in a two-bottle choice paradigm (β4
injected mice: 36.58± 5.8%, p < 0.05) compared to mice injected
with the PE control virus (51.35 ± 4.2%, p < 0.05). The nico-
tine aversion observed in wt mice injected with β4 lentivirus is
less pronounced than the one observed in transgenic Tabac mice
(11.86 ± 2.90% nicotine, p < 0.05), most likely because of higher
expression of β4 achieved in Tabac transgenic mice [which con-
tain more than 20 copies of the BAC encoding Chrnb4-a3-EGFP,
(Frahm et al., 2011)] than in mice injected with the β4-lentivirus
(Figure 6B). Mice injected with the lentivirus encoding the
β4T374I gain-of-function variant also showed reduced nicotine
intake (39.54 ± 3.6%, p < 0.05), while mice expressing the loss-
of-function β4R349C variant showed no alteration in nicotine
consumption (51.15 ± 8.4%, p < 0.05) with respect to the mice
injected with the PE control virus (Figure 6B). Thus, our studies
support a protective nature for the β4T374I variant in the animal
model, in agreement with genome-wide association studies that
linked the corresponding SNP T375I in CHRNB4 to decreased
risk for nicotine addiction in humans (Haller et al., 2012).
FIGURE 6 | Nicotine intake in mice injected in the Mhb with β4 and β4
missense variants. (A) Two-bottle choice nicotine consumption in Tabac
mice and in C57BL/6 mice after stereotactic, bilateral MHb injection of
lentivirus carrying control (PE), wild-type β4 or β4 containing the R348C or
T374I mutations constructs (n = 6–8 mice per group). All values are
expressed as mean ± s.e.m. One-Way ANOVA F(4, 29) = 25.25,
p < 0.0001; Dunnett’s Multiple Comparison post-hoc ∗p < 0.05, ∗∗p < 0.01,
∗∗∗p < 0.001. (B) Representative images of coronal brain sections showing
the site of lentivirus injection in MHb for PE, β4T374I, and β4R348C in
C57BL/6 mice or eGFP expression in the MHb and fasciculus retroflexus in
Tabac transgenic mice.
DISCUSSION
Chronic exposure to nicotine, the highly addictive component
of tobacco, is thought to alter the neural circuits to promote
changes that sustain the use of cigarettes (Paolini and De Biasi,
2011). The CHRNA5-A3-B4 gene cluster encoding the α5, α3,
and β4 and subunits of the nAChR has been linked with heavy
tobacco use and a high risk of relapse (Saccone et al., 2009).
The studies presented here establish that the β4 nicotinic receptor
subunit regulates nicotine intake in mice, that restricted expres-
sion of β4 in the MHb is sufficient to produce nicotine aversion,
and that four residues corresponding to CHRNB4 SNP variants
found in humans, A90I, T375I, R349C, and D444Y, have pro-
found effects on nicotine currents and nicotine consumption in
mice.
Three main conclusions can be drawn from these studies.
First, β4 is rate-limiting in the formation of α3β4∗ nAChRs.
Hence when β4 is overexpressed, either in transgenic Tabac mice,
carrying several copies of a transgene of the Chrnb4-Chrna3-
GFP-Chrna5 gene cluster, or by lentivirus-mediated transduction,
the presence of supplementary β4 subunits favors the recruit-
ment of α3 into additional α3β4 receptors. This β4-mediated
upregulation of α3β4 nAChRs detected by ligand binding, elec-
trophysiological and immunoprecipitation assays indicates that
these additional α3β4 receptors are at the plasma membrane.
This is important to consider in the context of nAChR dynamics
and trafficking and the effect of nicotine on receptor upregu-
lation. For instance, it has been shown that nicotine enhances
pentamer assembly of the α3β4 nAChR combination (Mazzo
et al., 2013). Since unassembled subunits are rapidly degraded
by the endoplasmic-reticulum-associated protein degradation
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process (Christianson and Green, 2004), and efficient assem-
bly of this nAChR subtype has been reported (Wang et al.,
1998; Sallette et al., 2004), it is very plausible that increasing
the number of available β4 subunits increases assembly and con-
tributes to the α3β4 receptor upregulation that we have observed
in Tabac mice and β4-lentivirus injected mice. Consistent with
this hypothesis, recent studies have shown that α3β4 pentamers
with three instead of two β4 subunits are less prone to degra-
dation. This β4 protective effect depends on the endoplasmic
reticulum export motif present in β4 345(LFM)347 which is lack-
ing in α3 (Mazzo et al., 2013). Interestingly, this motif lies at
one residue distance from the loss-of-function R349C variant
that we have identified in our functional assays. Consistently,
this mutant shows decreased currents and reduced membrane
insertion (Moriconi et al., 2011; Richards et al., 2011). Hence
these studies on β4 variants, together with our previous work
showing that the native β4S435 residue has the unique capa-
bility to confer the rate limiting capability of β4 to other
beta nAChR subunits, strengthens the view that the β4 sub-
unit has a distinctive role in nAChR trafficking and assembly.
The fact that this subunit has recently been linked to nicotine
dependence further validates its key role in mediating nicotine
responses.
Second, this study provides a novel paradigm to test the influ-
ence of β4 variants in nicotine consumption in vivo. Because
of the unique capability of β4 to upregulate α3β4 nAChR activ-
ity, and because the MHb is such a small brain structure highly
enriched in α3β4 receptors, the possibility to test the behavioral
outcome of rare missense β4 variants in this system is valuable.
The two SNPs analyzed here, A90I in the extracellular domain
and T374I in the intracellular loop, have been linked to a reduced
risk of nicotine dependence in GWAS and shown to increase nico-
tine currents in transfected HEK293 cells (Haller et al., 2012).
Consistently, our screen of β4 missense variants identified these
two SNPs, and an additional unstudied SNP, D447Y, as the vari-
ants with significantly higher nicotine-elicited currents in oocytes
and in mammalian neurons. Subsequent viral-mediated expres-
sion of one of these gain-of-function alleles in the MHb resulted
in strong aversion for nicotine, in support of the decreased risk
of developing nicotine dependence in individuals carrying this
allele. We also identified a variant with 70% less currents than
native β4. This missense mutant, β4R348C, has not yet been iden-
tified in GWAS of nicotine dependence, but has been linked to
sALS (Sabatelli et al., 2009; Moriconi et al., 2011). Cellular stud-
ies have shown that the β4R349C mutation, independent of the
companion α subunit, causes a reduction in potency of both ACh
and nicotine, decreases the density of whole-cell current evoked
by maximal transmitter concentrations, and alters the kinetics of
ACh-evoked whole-cell currents (Moriconi et al., 2011; Richards
et al., 2011). Interestingly overexpression of this loss-of-function
mutant in the habenula fails to induce nicotine aversion in mice
in comparison tomice injected with native β4 or gain-of-function
β4 variants. It is important to note that wild-type β4 and the
β4348Cmutant contain their native S435 residue, which is able to
increase currents upon overexpression (Figure 2). Hence lentivi-
ral overexpression of β4348C will produce more functional α3β4
receptors and subsequently higher nicotine mediated currents
than if this mutant would be expressed in a knock-in situation,
comparable to a β4R348C human carrier. Of course, the use of
viral vectors has some limitations. Most notable are the facts
that viral transduction results in overexpression of the carried
gene, and that expression can sometimes occur in adjacent brain
areas. While these points need to be considered, the facts that we
have observed phenotypes consistent with the properties of the
mutant receptors documented in oocytes and hippocampal neu-
rons, and that very little expression of nAChR alpha subunits is
detected in the surrounding cell types (Allen Brain Atlas images
in supplementary material) that can combine with β4 to form
functional receptors, support the conclusions drawn based on
our viral expression studies. Another consideration to acknowl-
edge is that the two-bottle free-choice drinking test paradigm
used here measures aversion but not preference, and that mice
injected with the non-β4 carrying control virus consumed a simi-
lar nicotine volume as mice overexpressing the β4R348C. Based
on these considerations we can infer that if one single allele
of this mutant was present, mice would have shown preference
for nicotine. Thus, it would be interesting to assess whether
sALS patients carrying this mutation are more prone to develop
smoking dependence. From these data we can conclude that
increased β4-mediated nAChR currents increase aversion to nico-
tine, while decreased currents decrease aversion, in favor of the
hypothesis that the MHb-IPN pathway limits consumption of
high doses of nicotine. Hence these results are relevant in the
context of MHb-mediated control of nicotine consumption and
the possibility to employ β4 to enhance or depress habenular
activity.
Third, it is important to consider the fact that missense vari-
ants of β4 are so rare in the human population. For instance,
the β4R348C loss-of-function variant that decreases α3β4∗ cur-
rents to a similar extent as the α5D398N variant, and could
potentially be linked to nicotine dependence, is present only in
1.4% of the human population (Table 1), in stark contrast with
the rs16969968 corresponding to α5D398N present in 28.9%
of smokers (http://www.ncbi.nlm.nih.gov/projects/SNP/snpref.
cgi?rs=16969968). Given that the β4R348C mutation has been
associated with sALS and that β4 is present in ganglionic and
motor neurons, it is tempting to hypothesize that mutations
in β4 would be too damaging to be carried to the progeny.
The fact that smoking may enhance sALS (Armon, 2009) may
underlie the importance of α3β4∗ activity in enhancing dis-
ease susceptibility, in particular in association with ambient
causes such as cigarette smoking. Hence very few studies have
found significant associations of CHRNB4 itself with smok-
ing phenotypes, perhaps because it is the rate-limiting subunit
when assembling β4∗ nAChRs, suggesting that mutations in
this subunit are less tolerated and thus found less often in the
population.
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